Mereo BioPharma Group (MREO)
2.37
-0.03 (-1.25%)
At close: Mar 03, 2025, 11:43 AM
Mereo BioPharma Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| PE Ratio | -10.34 | -2.65 | 14.68 | -1.48 | -1.68 | -2.89 | -2.31 | -2.05 | n/a |
| PEG Ratio | 0.28 | 0.01 | -0.14 | -0.05 | 0.17 | 0.12 | 0.82 | n/a | n/a |
| PS Ratio | 30.47 | 60.04 | 5.12 | 617.53 | -480.41 | n/a | -27.31 | n/a | n/a |
| PB Ratio | 6.03 | 1.46 | 2.12 | -16.21 | 1.46 | 2.82 | 1.44 | 0.73 | n/a |
| P/FCF Ratio | -14.14 | -2.33 | -32.35 | -8.56 | -1.28 | -3.99 | -2.6 | -2.12 | n/a |
| P/OCF Ratio | -14.42 | -2.33 | -35.65 | -8.56 | -1.28 | -4 | -2.79 | -2.13 | n/a |
| OCF/S Ratio | -2.11 | -25.76 | -0.14 | -72.11 | 376.48 | n/a | 9.79 | n/a | n/a |
| Debt / Equity Ratio | 0.12 | 0.21 | 0.19 | -1.2 | 0.81 | 0.66 | 0.33 | 0.04 | 0.03 |
| Quick Ratio | 6.72 | 2.63 | 8.06 | 4.01 | 1.42 | 2.15 | 6.83 | 35.74 | 28.85 |
| Current Ratio | 6.72 | 2.52 | 7.92 | 3.47 | 1.02 | 2.13 | 6.57 | 18.94 | 28.85 |
| Asset Turnover | 0.15 | 0.02 | 0.29 | 0.01 | -0.00 | n/a | -0.03 | n/a | n/a |
| Interest Coverage | -9.86 | -12.96 | -5.23 | -5.89 | -11.3 | -14.91 | -41.57 | -201.26 | n/a |
| Return on Equity (ROE) | -0.58 | -0.55 | 0.14 | 10.93 | -0.87 | -0.98 | -0.62 | -0.36 | n/a |
| Return on Assets (ROA) | -0.44 | -0.39 | 0.10 | -2.6 | -0.4 | -0.48 | -0.4 | -0.33 | n/a |
| Return on Capital (ROIC) | -0.5 | -0.69 | -0.18 | -0.69 | -0.7 | -0.69 | -0.52 | -0.43 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 74.26% | 37.89% | 50.89% | -4.06K% | 19.45K% | n/a | 1.15K% | n/a | n/a |
| Net Profit Margin | -294.66% | -2.27K% | 34.90% | -41.64K% | 28.56K% | n/a | 1.18K% | n/a | n/a |
| Pretax Profit Margin | -299.98% | -2.4K% | 39.05% | -42.35K% | 33.7K% | n/a | 1.43K% | n/a | n/a |
| Operating Profit Margin | -284.16% | -2.89K% | -57.42% | -9.56K% | 32.39K% | n/a | 1.38K% | n/a | n/a |
| FCF Margin | -215.51% | -2.58K% | -15.83% | -7.22K% | 37.67K% | n/a | 1.05K% | n/a | n/a |
| EBITDA Margin | -260.56% | -2.79K% | -13.72% | -9.55K% | 30.79K% | n/a | 1.35K% | n/a | n/a |